Jamieson Wellness Inc (JWEL) fair value: what the stock is really worth
As of Oct 23, 2026: fair value (intrinsic value) of Jamieson Wellness Inc stock C$30.71, price C$45.49, upside -32.5%, quality 64 out of 100. Rating: overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Fair value above price?No
Good quality?Yes
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 22, 2026.
How to read this chart
60‑month range C$20.62 – C$45.75 · fair‑value band C$14.56 – C$39.92 · the C$45.49 price screens above the C$30.71 fair value. Dashed = 300-day average. As of Oct 22, 2026.
Follow Jamieson Wellness in your weekly email
Every Wednesday you see whether Jamieson Wellness is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells the natural health products for human in Canada, the United States, China, and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners.
Show moreShow less
The Jamieson Brands segment manufactures, distributes, and markets branded natural health products, including vitamins, minerals, and supplements as well as sports nutrition products. The Strategic Partners segment provides contract manufacturing services to consumer health companies and retailers.
It offers health and wellness supplements under the Jamieson brand; health, beauty, and wellness supplements under the Youtheory brand; and foundational formulas, including probiotics, multivitamins, fish oils, vitamin D, and solution-focused products for better sleep or digestion under the Progressive brand.
The company also provides plant-based products under the Iron Vegan brand; natural health products for health concerns among women comprising hormone imbalances, nutrient deficiencies, sleep and stress management, and others under the Smart Solutions brand; and sports nutrition supplements under the Precision brand.
It sells its products to distributors, retail, and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada.
Stock analysis
Jamieson Wellness Inc (JWEL) currently trades at C$45.49, while our model-based Fair Value estimate is C$30.71, 32.5% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of C$31.42 per share, and 1 of the 24 models we run sit above the C$45.49 price.
Bear case: the Economic Profit group reads lowest at C$10.61, and 23 of the 24 models stay below the price. Data coverage for this calculation is high.
Scenario range: C$14.56 (bear) to C$39.92 (bull), the price of C$45.49 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 64/100 (solid quality), in the Consumer Defensive sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Jamieson Wellness Inc reported revenue of C$822M in FY2025 versus C$451M in FY2021, a compound +16.2%/yr. Reported net income was C$62.4M in FY2025, compounding +4.6%/yr from FY2021.
Key figures
Market cap C$2.0B (≈ $1.4B) Small · P/E ratio 24.9 · P/S ratio 2.22 · EPS (TTM) C$1.83 · Dividend yield 1.9% · Net margin 8.9% · Return on equity 15.3% · Return on assets (EBIT) 9.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 49 out of 100 (low confidence).
What moves the price
The share trades about 1% below its 52-week high and 41% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −19% fair-value upside, at −32%, JWEL screens richer than that median.
Fair Value models
BearC$14.56Fair Value C$30.71BullC$39.92
Price C$45.49 · Upside -32.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (C$0.7808 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.95/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+12.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.3%
Start year 2020 (pandemic). Over 10 years: +13.5% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.1%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+9.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+7.6%
Dividend (yield on the price)1.9%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 14%
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+22.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+9.3%
Yearly sales growth analysts expect, extended to five years.
After inflation (Canada: IMF forecast 2.1% a year to 2030, 2.6% from 2016 to 2025) that is about +19.9% a year for the price and +7.0% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 635 stocks
Beats the industry median on 6/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score64 · Top 25%
Fair Value upside−32.5% · Below median
Profitability
Return on equity (12 months)15.3% · Top 25%
Return on assets5.1% · Above median
Net margin (12 months)8.9% · Top 25%
Operating margin (12 months)12.7% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)17.4% · Top 25%
Dividend yield (12 months)1.9% · Below median
Balance sheet
Debt / equity0.85× · Highest 25%
Valuation Multiplesvs Packaged Foods median · lower = cheaper
P/E (12 months)24.9× · Pricier than median
P/B4.03× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months)2.22× · Priciest 25%
Price / free cash flow28.0× · Priciest 25%
EV/EBITDA16.0× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 37
FUTURE (revenue growth)87· sector 22
PAST (return on equity)61· sector 31
HEALTH (low debt)57· sector 96
DIVIDEND (yield)39· sector 57
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Jamieson Wellness Inc (JWEL) overvalued or undervalued?
As of Oct 22, 2026, our model estimates a fair value of C$30.71 versus a price of C$45.49, about −32% upside (overvalued).
What is the fair value of JWEL?
Our model-based fair value for Jamieson Wellness Inc is C$30.71 (as of Oct 22, 2026), built from audited fundamentals. The current price: C$45.49.
What is the quality score of JWEL?
Jamieson Wellness Inc has a Quality Score of 64/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Jamieson Wellness Inc (JWEL)?
Our model-based price target is the fair value of C$30.71 (as of Oct 22, 2026) from 24 valuation models. Cautious scenario C$14.56, optimistic scenario C$39.92. It is a calculation from audited fundamentals, not an analyst target.
What is the Jamieson Wellness Inc stock forecast for 2026?
Our models put fair value at C$30.71, about −32% upside versus a price of C$45.49 (overvalued). Cautious scenario C$14.56, optimistic scenario C$39.92. The calculation is refreshed regularly with new filings.
What is the revenue of Jamieson Wellness Inc (JWEL)?
Jamieson Wellness Inc reported trailing-twelve-month revenue of about C$881M (latest available figure, as of Oct 22, 2026).
Does Jamieson Wellness Inc pay a dividend?
Jamieson Wellness Inc currently shows a dividend yield of 1.93% relative to its recent price (as of Oct 22, 2026).
What growth is priced into Jamieson Wellness Inc (JWEL)?
For today's price to be fair in a discounted-cash-flow model, Jamieson Wellness Inc would have to grow free cash flow by +22.4 % per year for five years (discount rate 10.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +15.3 % per year. As of Oct 22, 2026.
What discount rate (WACC) does the fair value of JWEL use?
Our models discount Jamieson Wellness Inc at 10.9 %: a base by market capitalisation (small), damped by beta 0.95, country premium for Canada. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Jamieson Wellness Inc that is +22.4 % per year a year over ten years, using the same discount rate (10.9 %) and the same formula as our fair value.
How much growth has Jamieson Wellness Inc (JWEL) delivered so far?
Over the past 5 years revenue at Jamieson Wellness Inc grew +15.3 % a year. The price currently implies +22.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Jamieson Wellness Inc (JWEL) growing?
The median revenue growth in the sector is +3.3 % a year. That is the yardstick for the growth priced into Jamieson Wellness Inc (+22.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Jamieson Wellness Inc (JWEL)?
The free-cash-flow yield on the price is 3.57 %: that much free cash flow Jamieson Wellness Inc produces per unit of market value. When it exceeds the discount rate of our models (10.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Jamieson Wellness Inc (JWEL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Jamieson Wellness Inc it is C$30.71 per share (as of Oct 22, 2026), against a price of C$45.49. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Jamieson Wellness Inc stock overvalued or undervalued in 2026?
As of Oct 22, 2026, JWEL trades above its calculated fair value: price C$45.49, fair value C$30.71, a gap of about −32% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of JWEL?
No. The price is what the market pays today (C$45.49); the fair value is what the company's own numbers justify (C$30.71). For Jamieson Wellness Inc the two are C$14.78 per share apart. That gap is exactly why we show both numbers side by side.
How much is Jamieson Wellness Inc worth?
The market values Jamieson Wellness Inc at about C$2.0B (market capitalisation, as of Oct 22, 2026). Per share that is C$45.49; our models calculate a fair value of C$30.71 per share.
What do the bullish and bearish scenarios say about JWEL?
Our models span a range for Jamieson Wellness Inc: cautious scenario C$14.56, base C$30.71, optimistic C$39.92 per share (as of Oct 22, 2026, price C$45.49). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of JWEL?
Jamieson Wellness Inc trades at a price-to-earnings ratio of 24.9 (as of Oct 22, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of C$30.71 is built from several models across several years. Other multiples: P/B 4.0, P/S 2.2, EV/EBITDA 16.0.
How solid is the balance sheet of Jamieson Wellness Inc (JWEL)?
Balance-sheet figures for Jamieson Wellness Inc (as of Oct 22, 2026): return on equity 15.3%, debt of 0.85 per unit of equity. They feed the Quality Score of 64/100, which measures business quality independently of the share price.
How far is JWEL from its 52-week high?
Jamieson Wellness Inc trades at C$45.49, about 1% below its 52-week high of C$45.75 and 41% above the low of C$32.24 (as of Oct 23, 2026). Distance from the high says nothing about value: that is what the fair value of C$30.71 is for.
Which stocks are comparable to Jamieson Wellness Inc?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Jamieson Wellness Inc stock attractive at the current price?
The data as of Oct 22, 2026: price C$45.49, calculated fair value C$30.71 (−32%), Quality Score 64/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of JWEL calculated?
We run Jamieson Wellness Inc through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of C$30.71, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.7 % above its aggregate fair value. Jamieson Wellness Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Jamieson Wellness Inc (JWEL)?
The closing price on Oct 23, 2026 was C$45.49. Our model-based fair value is C$30.71, about −32% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Jamieson Wellness Inc right now?
The price sits above even our optimistic bull case (C$39.92). The favourable scenario is already priced in. The model range is unusually wide (C$14.56 to C$39.92). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid but not exceptional quality (64/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of Jamieson Wellness Inc
How large is the market capitalisation of Jamieson Wellness Inc (JWEL)?
The market capitalisation of Jamieson Wellness Inc is C$2.0B (≈ $1.4B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Jamieson Wellness Inc (JWEL)?
The price-to-sales ratio of Jamieson Wellness Inc is 2.22 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Jamieson Wellness Inc (JWEL)?
Earnings per share at Jamieson Wellness Inc are C$1.83 (price ÷ EPS = P/E 24.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Jamieson Wellness Inc (JWEL)?
The dividend yield of Jamieson Wellness Inc is 1.9% (payout 48.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Jamieson Wellness Inc (JWEL)?
The net margin of Jamieson Wellness Inc is 8.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Jamieson Wellness Inc (JWEL)?
The return on equity (ROE) of Jamieson Wellness Inc is 15.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Jamieson Wellness Inc (JWEL)?
On an EBIT basis the return on assets of Jamieson Wellness Inc is 9.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Jamieson Wellness Inc (JWEL)?
The operating margin of Jamieson Wellness Inc is 12.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Jamieson Wellness Inc (JWEL)?
Revenue at Jamieson Wellness Inc is growing +17.4% versus a year earlier (3y avg +14.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Jamieson Wellness Inc (JWEL)?
Earnings per share at Jamieson Wellness Inc are growing +40.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Jamieson Wellness Inc (JWEL) carry?
The net debt of Jamieson Wellness Inc is C$431M (fiscal year 2025, ≈ 6.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Jamieson Wellness Inc in the live analysis
One click puts Jamieson Wellness Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Broad data
Oct 22, 2026